Bleselumab

Add links
Source: Wikipedia, the free encyclopedia.
Bleselumab
CD40
Clinical data
Other namesASKP1240
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6412H9906N1690O2018S38
Molar mass144175.87 g·mol−1

Bleselumab (

organ transplant rejection.[2][3]

This drug was developed by Kyowa Kirin Pharmaceutical Development Inc.[4]

References

  1. ^ World Health Organization (2015). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 113" (PDF). WHO Drug Information. 29 (2).
  2. S2CID 4379881
    .
  3. PMID 27472094
    .
  4. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Bleselumab, American Medical Association.
Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Bleselumab&oldid=1124068672"